Scott M. Schuetze

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack et al. · The Lancet Oncology · 2017 · 1.4K citations · Full text

Oncology, Pathology, Advanced Soft-tissue Sarcoma +5

NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors

George D. Demetri, Margaret von Mehren, Cristina R. Antonescu et al. · Journal of the National Comprehensive Cancer Network · 2010 · 1.2K citations

Surgical Oncology, Immunology, Gastroenterology +18

Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Margaret von Mehren, John M. Kane, Mark Agulnik et al. · Journal of the National Comprehensive Cancer Network · 2022 · 1.1K citations · Full text

Surgical Oncology, Tumoral Pathology, Soft Tissue Sarcoma +15

Integrative clinical genomics of metastatic cancer

Dan R. Robinson, Yi-Mi Wu, Robert J. Lonigro et al. · Nature · 2017 · 904 citations · Full text

Tumor Heterogeneity, Medicine, Integrative Clinical Genomics +5

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial

George D. Demetri, Margaret von Mehren, Robin L. Jones et al. · Journal of Clinical Oncology · 2015 · 809 citations · Full text